Community Acquired Infections Pipeline Highlights - 2017 - Research and Markets

DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "Community Acquired Infections Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Community Acquired Infections Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Community Acquired Infections market. It covers emerging therapies for Community Acquired Infections in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Community Acquired Infections pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Community Acquired Infections pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Community Acquired Infections pipeline products by the company.

Short-term Launch Highlights:

Find out which Community Acquired Infections pipeline products will be launched in the US and Ex-US till 2020.

Summary:

• Community Acquired Infections phase 3 clinical trial pipeline products
• Community Acquired Infections phase 2 clinical trial pipeline products
• Community Acquired Infections phase 1 clinical trial pipeline products
• Community Acquired Infections preclinical research pipeline products
• Community Acquired Infections discovery stage pipeline products
• Community Acquired Infections pipeline products short-term launch highlights
  

Key Topics Covered:

1. Community Acquired Infections Pipeline by Stages

2. Community Acquired Infections Pipeline by Drug Class

3. Community Acquired Infections Pipeline by Company

4. Community Acquired Infections Phase 3 Clinical Trial Insights

5. Community Acquired Infections Phase 2 Clinical Trial Insights

6. Community Acquired Infections Phase 1 Clinical Trial Insights

7. Community Acquired Infections Preclinical Research Insights

8. Community Acquired Infections Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/7hgd4c/community

View source version on businesswire.com: http://www.businesswire.com/news/home/20170120005206/en/